NYSE:STVN Stevanato Group - STVN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. €25.90 +0.35 (+1.37%) (As of 03/31/2023 08:55 PM ET) Add Compare Share Share Today's Range€25.30▼€26.0650-Day Range€19.59▼€25.9052-Week Range€13.35▼€26.06Volume175,900 shsAverage Volume283,286 shsMarket Capitalization$7.65 billionP/E Ratio46.25Dividend YieldN/APrice Target€29.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Stevanato Group MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside12.0% Upside€29.00 Price TargetShort InterestHealthy0.22% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.83Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth10.94%From €0.64 to €0.71 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.24 out of 5 starsMedical Sector265th out of 996 stocksSurgical & Medical Instruments Industry23rd out of 104 stocks 2.5 Analyst's Opinion Consensus RatingStevanato Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of €29.00, Stevanato Group has a forecasted upside of 12.0% from its current price of €25.90.Amount of Analyst CoverageStevanato Group has only been the subject of 4 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.22% of the float of Stevanato Group has been sold short.Short Interest Ratio / Days to CoverStevanato Group has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Stevanato Group has recently decreased by 16.56%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldStevanato Group does not currently pay a dividend.Dividend GrowthStevanato Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for STVN. Previous Next 2.7 News and Social Media Coverage News SentimentStevanato Group has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.33 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Stevanato Group this week, compared to 1 article on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stevanato Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.70% of the stock of Stevanato Group is held by insiders.Percentage Held by InstitutionsOnly 10.27% of the stock of Stevanato Group is held by institutions. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Stevanato Group are expected to grow by 10.94% in the coming year, from €0.64 to €0.71 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stevanato Group is 46.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.12.Price to Earnings Ratio vs. SectorThe P/E ratio of Stevanato Group is 46.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 128.16.Price to Book Value per Share RatioStevanato Group has a P/B Ratio of 7.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Stevanato Group (NYSE:STVN) StockStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.Read More Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Email Address STVN Stock News HeadlinesMarch 31, 2023 | finance.yahoo.comDoes Stevanato Group S.p.A. (NYSE:STVN) Create Value For Shareholders?March 26, 2023 | americanbankingnews.comHead-To-Head Review: Stevanato Group (STVN) vs. Its PeersApril 2, 2023 | Investorplace Media (Ad)5 Hypergrowth Stocks to Buy NowLuke Lango has found 14 stocks that have gone up over 1,000%. Now he’s named his top stocks for 2023. Just click to claim your copy. March 25, 2023 | finanznachrichten.deStevanato Group S.p.A.: Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to MarketMarch 21, 2023 | finance.yahoo.comStevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to MarketMarch 16, 2023 | finance.yahoo.comStevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological ProductsMarch 9, 2023 | investing.comStevanato Group S.p.A. PT Raised to $27 at Wells FargoMarch 8, 2023 | finance.yahoo.comStevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global GrowthApril 2, 2023 | Investorplace Media (Ad)5 Hypergrowth Stocks to Buy NowLuke Lango has found 14 stocks that have gone up over 1,000%. Now he’s named his top stocks for 2023. Just click to claim your copy. March 7, 2023 | finance.yahoo.comSurging Earnings Estimates Signal Upside for Stevanato (STVN) StockMarch 4, 2023 | seekingalpha.comStevanato Group S.p.A. (STVN) Q4 2022 Earnings Call TranscriptMarch 4, 2023 | finance.yahoo.comStevanato Group Full Year 2022 Earnings: Beats ExpectationsMarch 3, 2023 | msn.comThe Latest Analyst Ratings for Stevanato GroupMarch 3, 2023 | finance.yahoo.comFull Year 2022 Stevanato Group SpA Earnings CallMarch 2, 2023 | msn.comStevanato Group (STVN) Surpasses Q4 Earnings and Revenue EstimatesMarch 2, 2023 | msn.comStevanato Group Non-GAAP EPS of €0.19, revenue of €292.1MMarch 2, 2023 | finance.yahoo.comStevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial ResultsMarch 1, 2023 | msn.comA Preview Of Stevanato Group's EarningsFebruary 28, 2023 | finance.yahoo.comPacira (PCRX) Matches Q4 Earnings EstimatesFebruary 27, 2023 | finance.yahoo.comRecursion Pharmaceuticals (RXRX) Reports Q4 Loss, Misses Revenue EstimatesFebruary 27, 2023 | finance.yahoo.comRecursion Pharmaceuticals (RXRX) Reports Q4 Loss, Misses Revenue EstimatesFebruary 24, 2023 | seekingalpha.comSTVN Stevanato Group S.p.A.February 24, 2023 | finance.yahoo.com15 Most Profitable New Stocks TodayFebruary 16, 2023 | businesswire.comStevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023January 24, 2023 | finance.yahoo.comStevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for PharmaJanuary 3, 2023 | finance.yahoo.comStevanato Group (NYSE:STVN) investors are sitting on a loss of 12% if they invested a year agoDecember 7, 2022 | finance.yahoo.comEstimating The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Email Address STVN Company Calendar Last Earnings3/02/2023Today4/01/2023Next Earnings (Estimated)5/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:STVN CUSIPN/A CIK1849853 Webwww.stevanatogroup.com Phone39049931811FaxN/AEmployees5,260Year FoundedN/APrice Target and Rating Average Stock Price Forecast€29.00 High Stock Price Forecast€32.00 Low Stock Price Forecast€27.00 Forecasted Upside/Downside+12.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)€0.56 Trailing P/E Ratio46.25 Forward P/E Ratio40.47 P/E GrowthN/ANet Income$150.51 million Net Margins14.49% Pretax Margin19.08% Return on Equity15.53% Return on Assets9.28% Debt Debt-to-Equity Ratio0.15 Current Ratio1.83 Quick Ratio1.37 Sales & Book Value Annual Sales$1.04 billion Price / Sales7.38 Cash Flow€0.77 per share Price / Cash Flow33.85 Book Value€3.55 per share Price / Book7.30Miscellaneous Outstanding Shares295,540,000Free Float293,471,000Market Cap$7.65 billion OptionableNot Optionable Beta0.66 Key ExecutivesMr. Franco Stevanato (Age 50)Exec. Chairman Mr. Franco Moro (Age 60)CEO, COO & Director Mr. Marco Dal Lago (Age 51)Chief Financial Officer Mr. Paolo Patri (Age 53)Chief Technology Officer Ms. Lisa MilesSr. VP of Investor RelationsMr. Mauro Stocchi (Age 57)Chief Bus. Officer Mr. Riccardo ButtaPres of AmericasMore ExecutivesKey CompetitorsShockwave MedicalNASDAQ:SWAVInspire Medical SystemsNYSE:INSPNovoCureNASDAQ:NVCRGlobus MedicalNYSE:GMEDPenumbraNYSE:PENView All CompetitorsInstitutional OwnershipTruist Financial CorpSold 3,231 shares on 2/17/2023Ownership: 0.004%State of WyomingBought 3,556 shares on 2/16/2023Ownership: 0.003%Advantage Alpha Capital Partners LPSold 207,603 shares on 2/15/2023Ownership: 0.216%Morgan StanleyBought 79,649 shares on 2/15/2023Ownership: 0.080%Legal & General Group PlcBought 1,898 shares on 2/15/2023Ownership: 0.012%View All Institutional Transactions STVN Stock - Frequently Asked Questions Should I buy or sell Stevanato Group stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stevanato Group in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STVN shares. View STVN analyst ratings or view top-rated stocks. What is Stevanato Group's stock price forecast for 2023? 4 brokerages have issued 1-year price targets for Stevanato Group's stock. Their STVN share price forecasts range from €27.00 to €32.00. On average, they anticipate the company's share price to reach €29.00 in the next twelve months. This suggests a possible upside of 12.0% from the stock's current price. View analysts price targets for STVN or view top-rated stocks among Wall Street analysts. How have STVN shares performed in 2023? Stevanato Group's stock was trading at €17.97 at the beginning of the year. Since then, STVN stock has increased by 44.1% and is now trading at €25.90. View the best growth stocks for 2023 here. Are investors shorting Stevanato Group? Stevanato Group saw a decrease in short interest in March. As of March 15th, there was short interest totaling 659,600 shares, a decrease of 16.6% from the February 28th total of 790,500 shares. Based on an average daily volume of 281,000 shares, the days-to-cover ratio is presently 2.3 days. Approximately 0.2% of the company's stock are sold short. View Stevanato Group's Short Interest. When is Stevanato Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. View our STVN earnings forecast. How were Stevanato Group's earnings last quarter? Stevanato Group S.p.A. (NYSE:STVN) released its earnings results on Thursday, March, 2nd. The company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.03. The company earned $292.10 million during the quarter, compared to analyst estimates of $271.89 million. Stevanato Group had a net margin of 14.49% and a trailing twelve-month return on equity of 15.53%. Stevanato Group's revenue was up 25.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.15 EPS. How often does Stevanato Group pay dividends? What is the dividend yield for Stevanato Group? Stevanato Group declared a -- dividend on Wednesday, June 8th. Shareholders of record on Tuesday, June 14th will be given a dividend of 0.051 per share on Wednesday, July 13th. This represents a dividend yield of 0.4%. The ex-dividend date is Monday, June 13th. Read our dividend analysis for STVN. What ETFs hold Stevanato Group's stock? ETFs with the largest weight of Stevanato Group (NYSE:STVN) stock in their portfolio include Goldman Sachs Future Health Care Equity ETF (GDOC), First Trust International IPO ETF (FPXI), First Trust IPOX Europe Equity Opportunities ETF (FPXE), SPDR S&P Kensho New Economies Composite ETF (KOMP) and iShares Biotechnology ETF (IBB). What guidance has Stevanato Group issued on next quarter's earnings? Stevanato Group updated its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided earnings per share guidance of $0.59-$0.63 for the period, compared to the consensus estimate of $0.58. The company issued revenue guidance of $1.11 billion-$1.14 billion, compared to the consensus revenue estimate of $1.10 billion. When did Stevanato Group IPO? (STVN) raised $720 million in an initial public offering on Friday, July 16th 2021. The company issued 32,000,000 shares at a price of $21.00-$24.00 per share. What is Stevanato Group's stock symbol? Stevanato Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "STVN." How do I buy shares of Stevanato Group? Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Stevanato Group's stock price today? One share of STVN stock can currently be purchased for approximately €25.90. How much money does Stevanato Group make? Stevanato Group (NYSE:STVN) has a market capitalization of $7.65 billion and generates $1.04 billion in revenue each year. The company earns $150.51 million in net income (profit) each year or €0.56 on an earnings per share basis. How many employees does Stevanato Group have? The company employs 5,260 workers across the globe. How can I contact Stevanato Group? Stevanato Group's mailing address is PIOMBINO DESE (PD) VIA MOLINELLA 17, PADUA L6, 35017. The official website for the company is www.stevanatogroup.com. The company can be reached via phone at 39049931811 or via email at ir@stevanatogroup.com. This page (NYSE:STVN) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.